MindWalk Holdings Corp. functions as an innovative bio-native artificial intelligence firm. Its core mission involves leveraging the synergy of AI, comprehensive multi-omics data, and sophisticated laboratory investigations to accelerate the identification and advancement of biological therapeutics. Utilizing its proprietary LensAI platform and HYFT technology, the company forges partnerships with pharmaceutical and biotechnology enterprises. These collaborations are designed to diminish the inherent risks associated with drug development and to unlock new possibilities for treatments. Founded in 1983, the company adopted its current name, MindWalk Holdings Corp., in September 2025, having previously been known as ImmunoPrecise Antibodies Ltd. Its corporate headquarters are located in Austin, Texas.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
based on 46.99M shares outstanding
CAMindWalk Holdings Corp. operates as a bio-native AI company.
It focuses on the integration of artificial intelligence, multi-omics data, and advanced laboratory research to accelerate the discovery and development of biologics.
The company, through its LensAI platform and HYFT technology, it partners with pharmaceutical and biotechnology companies to drive de-risk drug development and unlock therapeutic possibilities.
The company was formerly known as ImmunoPrecise Antibodies Ltd. and changed its name to MindWalk Holdings Corp. in September 2025.
The company was incorporated in 1983 and is headquartered in Austin, Texas.
Jennifer Lynne Bath
Chief Executive Officer, President & Non-Independent Director
Richard Scott Areglado
Chief Financial Officer
Thomas Lynch
Chief Business Officer
Kari Graber
Vice President of Commercial Services
Employees
102
Country
CA
Sector
Healthcare
Website
mindwalkai.com
Loading congressional disclosures…
based on 46.99M shares outstanding
CA30d Avg
356.78K
60d Avg
231.34K
90d Avg
232.91K
